ADC Therapeutics to Present at November Investor Conferences

LAUSANNE, Switzerland, Nov. 4, 2024 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced participation in two investor conferences in November:Guggenheim Securities Healthcare Innovation ConferenceDate: November 11, 2024Presentation Time: 11:00 a.m. ETFormat: Fireside ChatSpeaker: Ameet Mallik, Chief Executive OfficerJefferies London Healthcare ConferenceDate: November 19, 2024Presentation Time: 11:00 ...